Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-165
Closed -$6K 6660
2019
Q2
$6K Sell
165
-330
-67% -$11.3K ﹤0.01% 6645
2019
Q1
$15K Sell
495
-2,706
-85% -$82.7K ﹤0.01% 6441
2018
Q4
$89K Buy
+3,201
New +$87.9K ﹤0.01% 5119

Other funds holding ACA

Barclays's ACA Position: Q1 2026 in Review

Barclays reduced its Arcosa (ACA) stake by 86% in Q1 2026, selling an estimated $10.4M and leaving 15,223 shares worth $1.62M. The position accounts for ﹤0.01% of the portfolio, ranked #2491.

Barclays first reported a position in ACA in Q4 2018 and has held it in 30 quarters since. The position peaked at $11.4M in Q4 2025. 372 funds tracked by Wall St. Rank hold ACA as of Q1 2026.

  • Barclays held 15,223 shares of Arcosa worth $1.62M as of Q1 2026.
  • Barclays sold 91,692 Arcosa shares in Q1 2026, an estimated $10.4M.
  • Arcosa made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2491 holding.
  • Barclays first reported a position in Arcosa in Q4 2018 and has held it in 30 quarters since.
  • Barclays's Arcosa position peaked at $11.4M in Q4 2025.
  • 372 funds tracked by Wall St. Rank held Arcosa as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.